These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through ...

Interestingly, a group of scientists have discovered a new deleterious role of MMA in lung carcinoma ... progression and suppressing immune cell function. Gomes and others have discovered a novel ...

FDA approval of tarlatamab (Imdelltra) for small-cell lung cancer offers another example of progress. The novel bispecific ...

NKTR-255 in combination with durvalumab following chemoradiation was well-tolerated in patients with non–small cell lung ...

MSK identified a new subtype of small cell lung cancer in young non-smokers, challenging existing treatment paradigms with ...

Study Links Methylmalonic Acid to Weakening of Immune Cells in Lung Cancer Oct. 31, 2024 — A new study has found a surprising link between high levels of methylmalonic acid and the weakening of ...

Researchers from the University of Barcelona and the August Pi y Sunyer Biomedical Research Institute (IDIBAPS) have shown ...

In operable non-small cell lung cancer (NSCLC), molecular residual disease (MRD) detection via circulating tumor DNA (ctDNA) ...

We've made massive strides against the deadly disease, but rates haven't fallen for people diagnosed with the disease who've never smoked.

The 22nd Annual Winter Lung Cancer Conference, January 31-February 2, 2025, will cover advances in NSCLC and SCLC treatment.

Study results show that a portable breath analysis device designed for early detection of non–small cell lung cancer may distinguish between patients with the disease and healthy individuals.

The top stories in non-small cell lung cancer (NSCLC) for 2024 included practice-changing results in EGFR-mutant disease, an ...